Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

Doctors say a new antibody treatment and maternal vaccine could reduce RSV-related hospitalizations in infants.

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II clinical study of AK0610, a ...

RSV season is here, and now is the time to take preventative measures to avoid illness and emergency hospitalization. This ...

With symptoms including a cough, how can you know whether your child just has a cold or when it’s signs of RSV?

The cause of the pollution is largely fires set by humans to clear forest for cattle and pasturelands, according to the peer-reviewed findings ...

Hospitals around the state are seeing a spike in serious respiratory illnesses, and doctors say it’s happening earlier than usual. From RSV to the flu, children’s ...

Children are particularly vulnerable to post-festive health issues because of their natural curiosity and limited ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater numbers of babies and toddlers to the hospital for professional care.

In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...